RecallDepth
Class II Ongoing

chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01

This recall is currently active, issued January 1, 2025. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
December 11, 2024
Posted
January 1, 2025
Recall Number
D-0159-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3,888
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

Distribution

USA Nationwide

Lot / Code Info

Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls